Ramesh Rengan

Biography

Dr. Ramesh Rengan is currently Chair and Professor in the Department of Radiation Oncology at the University of Washington School of Medicine and Professor, Clinical Research Division of the Fred Hutchinson Cancer Research Center. He also holds a joint appointment as faculty of the Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center. His clinical interests include thoracic malignancies, melanomas (including ocular melanoma), renal cell carcinoma, and prostate cancer. Additionally, he has clinical expertise in the use of proton beam therapy in the management of localized and locally advanced solid tumors. His current research focuses on approaches to improve the therapeutic ratio in solid tumors to ionizing photon or proton radiation. His active area of current research is in pre-clinical and clinical strategies to utilize radiation to trigger an anti-tumor immune response in patients with advanced solid malignancies. He also has an interest in healthcare disparities and expanded access to radiation treatment in low-resource environments.

Abstract

An area of intense scientific interest is in the exploration of the relationship between the immune system and tumor progression. Multiple studies have demonstrated the importance of the immune system in cancer surveillance and treatment response and the aggressive clinical phenotype of malignancy in an immunocompromised host. This presentation will focus on the utilization of radiation an immune modulator that can augment other cancer immunotherapies in immunocompetent patients with locally advanced, oligometastatic and metastatic lung cancer. We will further discuss the current standard of care in cancer immunotherapy and the strengths and limitations of current approaches. Finally, we will discuss future initiatives aimed at trying to optimize radiation as a tool to generate a durable anti-tumor immune response.

Share This Speaker
Speaker Details
  • Location
  • Affiliations of the Speaker
    University of Washington/SCCA Proton Center
Radiation and Immune Modulation in Lung Cancer: Moving Beyond Local Control

8th November 2020,12:00pm

Events of the Speaker
You might also love these events.
Past
November 7, 2020
The highlights for the 7th HKIOS include application of artificial intelligence in radiotherapy planning and biomarkers discovery, ultra-high dose rate (FLASH) radiotherapy and alternating electric fields (tumour treating fields or TTF). Many oncologists are not familiar with these brand-new modalities, which are being slowly incorporated into our clinical practice. Due to Covid-19 pandemic, we shall conduct our symposium virtually. We thank our local and overseas speakers for their stern support and contribution again.